XML 75 R34.htm IDEA: XBRL DOCUMENT v3.3.0.814
SHAREHOLDERS' EQUITY (Tables)
 9 Months Ended
Sep. 30, 2015
Stockholders' Equity Note [Abstract]  
Schedule of Shareholders' equity
 
Valeant Pharmaceuticals International, Inc. Shareholders
 
 
 
 
 
Common Shares
 
Additional
Paid-In
Capital
 
Accumulated
Deficit
 
Accumulated
Other
Comprehensive
Loss
 
Valeant
Pharmaceuticals
International, Inc.
Shareholders’
Equity
 
Noncontrolling
Interest
 
Total
Equity
 
Shares
 
Amount
 
 
 
 
 
 
Balance, January 1, 2014
333.0

 
$
8,301.2

 
$
228.8

 
$
(3,278.5
)
 
$
(132.8
)
 
$
5,118.7

 
$
114.6

 
$
5,233.3

Common shares issued under share-based compensation plans
1.0

 
33.2

 
(23.6
)
 
—

 
—

 
9.6

 
—

 
9.6

Settlement of stock options
—

 
—

 
(3.1
)
 
—

 
—

 
(3.1
)
 
—

 
(3.1
)
Share-based compensation
—

 
—

 
60.6

 
—

 
—

 
60.6

 
—

 
60.6

Employee withholding taxes related to share-based awards
—

 
—

 
(38.5
)
 
—

 
—

 
(38.5
)
 
—

 
(38.5
)
Excess tax benefits from share-based compensation
—

 
—

 
17.1

 
—

 
—

 
17.1

 
—

 
17.1

Acquisition of noncontrolling interest
—

 
—

 
(1.1
)
 
—

 
—

 
(1.1
)
 
(2.2
)
 
(3.3
)
Noncontrolling interest distributions
—

 
—

 
—

 
—

 
—

 
—

 
(0.5
)
 
(0.5
)
 
334.0

 
8,334.4

 
240.2

 
(3,278.5
)
 
(132.8
)
 
5,163.3

 
111.9

 
5,275.2

Comprehensive income:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
—

 
—

 
—

 
378.6

 
—

 
378.6

 
(0.5
)
 
378.1

Other comprehensive income (loss)
—

 
—

 
—

 
—

 
(419.2
)
 
(419.2
)
 
(0.5
)
 
(419.7
)
Total comprehensive income
 
 
 
 
 
 
 
 
 
 
(40.6
)
 
(1.0
)
 
(41.6
)
Balance, September 30, 2014
334.0

 
$
8,334.4

 
$
240.2

 
$
(2,899.9
)
 
$
(552.0
)
 
$
5,122.7

 
$
110.9

 
$
5,233.6

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, January 1, 2015
334.4

 
$
8,349.2

 
$
243.9

 
$
(2,365.0
)
 
$
(915.9
)
 
$
5,312.2

 
$
122.3

 
$
5,434.5

Issuance of common stock (see below)
7.5

 
1,481.0

 
—

 
—

 
—

 
1,481.0

 
—

 
1,481.0

Common shares issued under share-based compensation plans
1.4

 
75.7

 
(46.6
)
 
—

 
—

 
29.1

 
—

 
29.1

Repurchases of common shares
(0.2
)
 
(6.3
)
 
—

 
(43.7
)
 
—

 
(50.0
)
 
—

 
(50.0
)
Share-based compensation
—

 
—

 
111.4

 
—

 
—

 
111.4

 
—

 
111.4

Employee withholding taxes related to share-based awards
—

 
—

 
(85.8
)
 
—

 
—

 
(85.8
)
 
—

 
(85.8
)
Excess tax benefits from share-based compensation
—

 
—

 
21.7

 
—

 
—

 
21.7

 
—

 
21.7

Noncontrolling interest from business combinations
—

 
—

 
—

 
—

 
—

 
—

 
4.9

 
4.9

Noncontrolling interest distributions
—

 
—

 
—

 
—

 
—

 
—

 
(7.0
)
 
(7.0
)
 
343.1

 
9,899.6

 
244.6

 
(2,408.7
)
 
(915.9
)
 
6,819.6

 
120.2

 
6,939.8

Comprehensive loss:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
—

 
—

 
—

 
70.2

 
—

 
70.2

 
4.4

 
74.6

Other comprehensive loss
—

 
—

 
—

 
—

 
(547.5
)
 
(547.5
)
 
(2.2
)
 
(549.7
)
Total comprehensive loss
 
 
 
 
 
 
 
 
 
 
(477.3
)
 
2.2

 
(475.1
)
Balance, September 30, 2015
343.1

 
$
9,899.6

 
$
244.6

 
$
(2,338.5
)
 
$
(1,463.4
)
 
$
6,342.3

 
$
122.4

 
$
6,464.7